Abstract
Oral progestins have been reported to be effective in the treatment of endometriosis. The mode of action is still a matter of debate, but it may involve modulation of mitotic activity, local growth factors and growth factor receptors, as well as other paracrine mechanisms and anti-inflammatory reactions. Other treatments such as danazol and GnRH-agonists are effective with regard to relief of symptoms and regression of the endometriotic implants, but are associated with high recurrence rates and a wide range of side effects. Progestins are therefore indicated in the symptomatic management of pain, bleeding disorders and other symptoms caused by endometriosis when long-term medication or repeated courses of treatment are indicated. The relationship between costs and efficacy is good, and the side effects are tolerable in most cases. Dydrogesterone is particularly suitable in cases where the woman desires to become pregnant and to prevent bleeding problems. Only very limited data are available concerning the use of progestins in adenomyosis and no conclusions can be drawn.
References
Mar 1, 1987·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·S TelimaaA Kauppila
Oct 7, 1997·Fertility and Sterility·P VercelliniP G Crosignani
Nov 24, 1998·Human Reproduction Update·C Wood
Aug 12, 2003·Fertility and Sterility·Paolo VercelliniPier Giorgio Crosignani
Aug 21, 2003·Human Reproduction Update·Paolo VercelliniPier Giorgio Crosignani
Dec 21, 2004·Human Reproduction·Farhana B LockhatJustin C Konje
Apr 6, 2006·Fertility and Sterility·William D SchlaffAgneta Bergqvist
Jul 26, 2008·Fertility and Sterility·Tasuku HaradaNaoki Terakawa
May 2, 2009·Drugs·Paolo VercelliniPier Giorgio Crosignani
Jun 27, 2009·Gynecologic and Obstetric Investigation·Sopon CheewadhanaraksSathana Bunyapipat
Citations
Sep 24, 2013·Japanese Journal of Clinical Oncology·Daisuke AkashiHidenori Kato
Sep 22, 2015·Women's Health·Altay Gezer, Engin Oral
Jan 23, 2016·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Matthias OlbrichKatsuhiro Mihara
Mar 8, 2011·Steroids·Tea Lanišnik RižnerBettina Husen
Mar 8, 2016·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Nilesh TrivediVishal Vaidya
May 19, 2012·Journal of Midwifery & Women's Health·Anne Z Cockerham
Dec 1, 2010·Hormone Molecular Biology and Clinical Investigation·Karl-Werner Schweppe
Dec 1, 2010·Hormone Molecular Biology and Clinical Investigation·Alfred O Mueck
Dec 19, 2012·Diagnostic and Interventional Imaging·G LevyE Poncelet
Mar 1, 2015·BMJ Case Reports·Tia Hunjan, Andrew Davidson
May 6, 2015·Reproductive Sciences·Fu-Qing SunJin-Jiao Li
Jan 1, 2012·Pharmaceuticals·Ozgul Muneyyirci-DelaleHans von Gizycki
Nov 19, 2015·Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology·M W P BarbosaW P Martins
Apr 20, 2021·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Petra Stute
Jul 16, 2021·Reproductive Medicine and Biology·Jo KitawakiMikio Momoeda
Sep 2, 2021·Fertility and Sterility·Gennady T SukhikhJan I Olofsson
Sep 3, 2010·Current Opinion in Obstetrics & Gynecology